An act relating to increasing the transparency of prescription drug costs and spending
This bill increases transparency around prescription drug costs in Vermont. It prohibits pharmacy benefit managers from requiring patients to pay more than the drug's average cost plus a standard dispensing fee (based on Vermont Medicaid rates). Pharmacies must post notices informing patients about available price options, including cash prices. Hospitals must report annual details about their participation in the federal 340B drug discount program to the Green Mountain Care Board, and health insurers must send patients annual reports showing actual drug spending on their behalf. These requirements directly affect patients, pharmacies, insurers, and healthcare providers.
Bill status
introduced
1 of 4 stages cleared
Introduction
Feb 2025
Committee Review
Floor Vote
Governor
Introduced Feb 12, 2025
Last action Feb 12, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Feb 12, 2025
Introduced
Read first time and referred to the Committee on Health Care
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Mari Cordes
DDemocratic/Progressive
Ask Maddy
·
AI policy assistant
Ask Maddy about H 202
Scope: VT
Hi! I can help you understand H 202. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline